Potential treatment-related AEs | |
Corneal abrasion | 11 (0.15) |
Lens injury | 1 (0.01) |
Endophthalmitis | 1 (0.01) |
Retinal detachment | 3 (0.04) |
Other | |
Mild discomfort | 10 (0.14) |
Itching | 1 (0.01) |
Transient raised IOP | 1 (0.01) |
Subconjunctival haeme | 2 (0.03) |
Potential drug-related ocular AEs | |
Inflammation/uveitis | 10 (0.14) |
Cataract progression | 1 (0.01) |
Acute vision loss | 5 (0.07) |
CRAO | 1 (0.01) |
Other | |
Increased/new SRH | 4 (0.06) |
RPE tears | 4 (0.06) |
Potential drug-related systemic AEs | |
Blood pressure increase | 15 (0.21) |
Deep venous thrombosis | 1 (0.01) |
Transient ischaemic attack | 1 (0.01) |
Cerebrovascular accident | 5 (0.07) |
Myocardial infarction | 0 (0) |
Death | 2 (0.03) |